Jci_page_head_homepage_01 Jci_page_head_homepage_02
Xueliang Du, Diane Edelstein, Silvana Obici, Ninon Higham, Ming-Hui Zou,, Michael Brownlee
Published in Volume 116, Issue 4
J Clin Invest. 2006; 116(4):1071–1080 doi:10.1172/JCI23354
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1
Schematic mechanism by which IR causes increased oxidation of FFA in arterial endothelial cells, activating proatherogenic signals and inhibiting antiatherogenic enzymes.

IR, insulin resistance; ACC, acetyl-CoA carboxylase; CPT-I, carnitine palmitoyltransferase I; AGE, advanced glycation end product; GlcNAc, N-acetylglucosamine; PGI2, prostacyclin.